1
1 of 2
- Addiction Recovery ClinicDana Clinic Building789 Howard AvenueNew Haven, CT 06519
- APT Foundation1 Long Wharf DriveNew Haven, CT 06511
Jeanette Tetrault, MD, FACP, FASAM
Addiction Medicine, General Internal Medicine
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine and Addiction Medicine
Biography
Jeanette M. Tetrault, MD, is an attending physician at Yale New Haven Hospital who also provides primary care and substance use disorder treatment at the central medical unit of the APT Foundation in New Haven, a multi-specialty addiction treatment facility that is affiliated with Yale New Haven Hospital. She focuses on patients with addiction and medical issues associated with substance use, including HIV and Hepatitis C
“I am dedicated to caring for patients from underserved communities,” says Dr. Tetrault, an associate professor of medicine (general medicine) at Yale School of Medicine. “Our nation currently faces a health care crisis related to opioid addiction, and I am pleased to provide nonjudgmental, evidence-based treatment to patients and families struggling with this chronic medical condition.”
As a researcher, Dr. Tetrault has published widely in the field of Addiction Medicine, including epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmacotherapies, and addiction medicine curriculum design, evaluation, and dissemination.
Titles
- Professor of Medicine (General Medicine)
- Program Director, Addiction Medicine Fellowship, Internal Medicine
- Academic Advisor, Office of Student Affairs
- Associate Director for Education and Training, Program in Addiction Medicine, Internal Medicine
- Vice-chief for Education, General Internal Medicine
- Professor, Chronic Disease Epidemiology
Education & Training
- Ambulatory Care FellowWest Haven VA Hospital (2007)
- Chief ResidentYale School of Medicine (2005)
- Medical Intern and ResidentYale School of Medicine (2004)
- MDBoston University School of Medicine (2001)
- BABoston University, Biology (1997)
Additional Information
Honors & Recognitions
- John P. McGovern Award for Excellence in Medical Education: Association for Multidisciplinary Education and Research in Substance Use and Addiction (2023)
- Annual Training Directors Award: American Society of Addiction Medicine (2021)
- Elected as President : American College of Academic Addiction Medicine (2019)
- Awarded W. Anderson Spickard Excellence in Mentorship Award: Association for Multidisciplinary Education and Research in Substance Use and Addiction (2018)
- Recognized Macy Foundation Faculty Scholar: Macy Foundation (2017)
- Elected as Milestones Committee Chair: The Addiction Medicine Foundation (2017)
- Elected President: Society of General Internal Medicine, New England Region (2014)
- Clinician Educator of the Year: Society of General Internal Medicine-New England Regional Award for Excellence (2013)
- George Thornton Community Teacher of the Year Award: Yale School of Medicine Primary Care Internal Medicine Residency Program (2011)
- Selected as Co-chair Alcohol, Tobacco, and Other Drug Use Interest Group: Society of General Internal Medicine (2011)
Board Certifications
- AB of Preventive Medicine, Addiction Medicine (2018)
Professional Service
- Yale New Haven Hospital-Ambulatory treatment of OUD pathway Committee (2022 - Present): Serve as a member of the YNHH ambulatory treatment of OUD pathway committee
- Yale School of Medicine-Medical Student Subcommittee of LCME Self Study (2022 - Present): Member of the medical student subcommittee of the YSM LCME Self Study Task Force
- Curbsiders Addiction Medicine Podcast (2022 - Present): Invited speaker for podcast focusing on decreasing stigma in addiction medicine
- American College of Academic Addiction Medicine (2022 - Present): President
- YSM-YNHH Addiction Medicine/Addiction Psychiatry Services Steering Committee (2021 - Present): Member
- NPR (2021 - Present): Invited guest on CT Public Radio to discuss alcohol use disorder in women
- Accreditation Council for Continuing Medical Education, Independent Grant Review Committee (2021 - 2023): Served as grant reviewer for REMS Program Companies that make and market opioids to provide commercial support to accredited continuing education for healthcare teams to promote safe prescribing and help combat the opioid crisis. Served in 2021 and 2022
- University of Washington (2020 - 2022): Serve as Independent Safety Monitor for NIDA Funded R34 (PI Judith Tsui, MD; University of Washington) pilot study of community pharmacy model for treating people who inject drugs who are infected with Hepatitis C
- American College of Academic Addiction Medicine (2019 - 2022): President-elect
- American College of Academic Addiction Medicine (2019 - Present): Chair, ACGME Milestones subcommittee
Publications
- Miller S, Levy S, Saxon A, Tetrault J, Rosenthal R, Wakeman S, Vocci F. Revisiting Preaddiction. Journal Of Addiction Medicine 2024 DOI: 10.1097/adm.0000000000001357.
- Haque L, Fiellin D, Bryant K, Edelman E, Justice A, Lim J, Re V, Marshall B, Taddei T, Tate J, Tetrault J, Williams E, McGinnis K. W31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis. Drug And Alcohol Dependence 2024, 260: 110649. DOI: 10.1016/j.drugalcdep.2023.110649.
- Mahoney B, Morford K, Biegacki E, Tetrault J. Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease 2024, 23: e0241. PMID: 38952692, PMCID: PMC11216679, DOI: 10.1097/cld.0000000000000241.
- Abdulfattah S, Ahmad A, Kitaneh R, Alsharaydeh T, Almudallal F, Alzoubi R, Abbadi R, Haddad T, Wazaify M, Alkayed Z, Mustafa R, Tetrault J. Nonmedical Use of Stimulants Among Students in Jordan: A Nationwide Study. Journal Of Addiction Medicine 2024, 18: 443-450. PMID: 38587298, DOI: 10.1097/adm.0000000000001308.
- Cavallo D, Salwan J, Doernberg M, Tetrault J, Holt S. Shared Medical Appointment: A Novel Model for Incorporating Group Visits Into Residency Training for Substance Use Disorders. Substance Use & Addiction Journal 2024, 45: 466-472. PMID: 38494709, DOI: 10.1177/29767342241233363.
- Morford K, Tetrault J, Fiellin D. The MATE Act: Progress for substance use education, but is checking a box enough? Journal Of General Internal Medicine 2024, 39: 1496-1498. PMID: 38308156, PMCID: PMC11169132, DOI: 10.1007/s11606-024-08652-7.
- Canver B, Liptak A, Clark K, Tetrault J, Holt S. Preparing Physicians to Treat Addiction: Inclusion of Dedicated Addiction Training During Internal Medicine Residency. Substance Use & Addiction Journal 2024, 45: 408-414. PMID: 38254274, DOI: 10.1177/29767342231224978.
- Kazemitabar M, Nyhan K, Makableh N, Minahan-Rowley R, Ali M, Wazaify M, Tetrault J, Khoshnood K. Epidemiology of substance use and mental health disorders among forced migrants displaced from the MENAT region: A systematic review and meta-analysis protocol. PLOS ONE 2023, 18: e0292535. PMID: 37797050, PMCID: PMC10553213, DOI: 10.1371/journal.pone.0292535.
- Entrup P, Brodsky L, Trimble C, Garcia S, Mohamed N, Deaner M, Martell J, Teater J, Jordan A, Tetrault J, Hall O. Years of life lost due to deaths of despair and COVID-19 in the United States in 2020: patterns of excess mortality by gender, race and ethnicity. International Journal For Equity In Health 2023, 22: 161. PMID: 37612748, PMCID: PMC10464324, DOI: 10.1186/s12939-023-01949-9.
- Huxley‐Reicher Z, Puglisi L, Tetrault J, Weimer M, Stellini M, Bhandary‐Alexander J, Thomas K, Donroe J. Response to substance use during hospitalization: A survey study of current and ideal policies and practices. Journal Of Hospital Medicine 2023, 18: 829-834. PMID: 37475186, DOI: 10.1002/jhm.13162.
- Brooks R, Wegener M, Freeman B, Fowles C, Madden L, Tetrault J, Nichols L, Altice F, Villanueva M. Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches. Health Promotion Practice 2023, 24: 1018-1028. PMID: 37439759, DOI: 10.1177/15248399231169791.
- Chan C, Tetrault J, Holt S. Leading a Substance Use Disorder Clinic. 2023, 255-274. DOI: 10.1007/978-3-031-40273-9_17.
- Haque L, Fiellin D, Tate J, Esserman D, Bhattacharya D, Butt A, Crystal S, Edelman E, Gordon A, Lim J, Tetrault J, Williams E, Bryant K, Cartwright E, Rentsch C, Justice A, Re V, McGinnis K. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. JAMA Network Open 2022, 5: e2246604. PMID: 36515952, PMCID: PMC9856353, DOI: 10.1001/jamanetworkopen.2022.46604.
- Morford K, Tetrault J, Zhou B, Li F, Gleeson B, Edelman E, Stein M, Barry D, Madden L. The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study. Drug And Alcohol Dependence 2022, 241: 109707. PMID: 36423462, PMCID: PMC9777057, DOI: 10.1016/j.drugalcdep.2022.109707.
- Morford KL, Batchelor HM, Tetrault JM. Grief at the Heart of the Opioid Overdose Crisis: Past Lessons and Present Implications. Journal Of Addiction Medicine 2022, 16: 613-615. PMID: 35165230, DOI: 10.1097/adm.0000000000000976.
- Barcelona V, Wischik DL, Marshall A, Tetrault JM. Integration of medication for opioid use disorder training into graduate nursing education. Nursing Forum 2022, 57: 869-873. PMID: 35616353, DOI: 10.1111/nuf.12753.
- Haque LY, Butner JL, Shi JM, Henry S, Deng Y, Ciarleglio MM, Madden LM, Tetrault JM. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting. Journal Of Addiction Medicine 2022, 16: 333-339. PMID: 34483278, PMCID: PMC9033626, DOI: 10.1097/adm.0000000000000910.
- Viera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection. Drug And Alcohol Dependence Reports 2022, 3: 100038. PMID: 36845980, PMCID: PMC9948939, DOI: 10.1016/j.dadr.2022.100038.
- Shi J, Slocum B, Tetrault J, Yanagisawa K. Chapter 9 Addiction management in the outpatient setting. 2022, 169-187. DOI: 10.1016/b978-0-323-79016-1.00008-8.
- Biegacki ET, Tetrault JM, Fiellin DA. Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine. Substance Abuse 2022, 43: 1215-1220. PMID: 35657646, DOI: 10.1080/08897077.2022.2074606.
- Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL. Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach. Journal Of Addiction Medicine 2021, 16: 399-406. PMID: 34954746, DOI: 10.1097/adm.0000000000000945.
- Du CX, Shi J, Tetrault JM, Madden LM, Barry DT. Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine. Family Practice 2021, 39: 234-240. PMID: 34893825, PMCID: PMC8947790, DOI: 10.1093/fampra/cmab166.
- Morford K, Falker C, Tetrault J. Training Medical Students, Residents, and Fellows in Opioid Use Disorder Treatment. 2021, 161-171. DOI: 10.1007/978-3-030-80818-1_11.
- Thompson SL, Gianessi CA, O'Malley SS, Cavallo DA, Shi JM, Tetrault JM, DeMartini KS, Gueorguieva R, Pittman B, Krystal JH, Taylor JR, Krishnan-Sarin S. Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants. Frontiers In Psychiatry 2021, 12: 709559. PMID: 34531767, PMCID: PMC8438169, DOI: 10.3389/fpsyt.2021.709559.
- Chan CA, Tetrault JM, Fiellin DA, Weimer MB. SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures Act. Journal Of Addiction Medicine 2021, 16: 141-142. PMID: 34049315, DOI: 10.1097/adm.0000000000000879.
- Oldfield BJ, Tetrault JM, Berland G. Addiction Screening—The A Star Is Born Movie Series and Destigmatization of Substance Use Disorders. JAMA 2021, 325: 915-917. PMID: 33687448, DOI: 10.1001/jama.2020.25256.
- Smetana GW, Tetrault JM, Hill KP, Burns RB. Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals Of Internal Medicine 2021, 174: 237-246. PMID: 33556279, DOI: 10.7326/m20-7945.
- Bisio C, Tetrault J. Association entre l’usage de cannabis et les principales anomalies congénitales. Revue Médicale Suisse 2021, 17: 1334. PMID: 34264039, DOI: 10.53738/revmed.2021.17.745.1334.
- Training medical students, residents, and fellows in opioid use disorder treatmentMorford, KL, Falker CG, Tetrault, JM. in Treating Opioid Use Disorder in General Medical Settings. Editor, Wakeman, SE.
- Treatment of Opioid Use DisorderRobinson, D and Tetrault JM. Treatment of Opioid Use Disorder in Pocket Medicine. Editor: Wakeman, SE
- Muvvala SB, Schwartz ML, Petrakis I, O'Connor P, Tetrault JM. Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical Training. Substance Abuse 2020, 41: 475-479. PMID: 31951809, DOI: 10.1080/08897077.2019.1709606.
- Severe B, Tetrault JM, Madden L, Heimer R. Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention. Drug And Alcohol Dependence 2020, 213: 108116. PMID: 32599493, DOI: 10.1016/j.drugalcdep.2020.108116.
- Haque LY, Jakab S, Deng Y, Ciarleglio MM, Tetrault JM. Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. Journal Of Addiction Medicine 2020, 14: e337-e343. PMID: 32530887, PMCID: PMC9033633, DOI: 10.1097/adm.0000000000000677.
- Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2020, 172: 774-775. PMID: 32479150, DOI: 10.7326/l20-0084.
- Tetrault JM, Holt SR, Cavallo DA, O'Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT. Journal Of Addiction Medicine 2020, 14: e303-e309. PMID: 32371660, DOI: 10.1097/adm.0000000000000663.
- Roberts A, Angoff NR, Brissette D, Dupee D, Fahs D, Honan L, Korbey S, Roessler E, Schwartz M, Shabanova V, Tetrault J, Wu B, Colson E, Encandela J. Burnout Among Beginning First-Year Students from Three Health Professional Training Programs. Medical Science Educator 2020, 30: 879-883. PMID: 34457745, PMCID: PMC8368543, DOI: 10.1007/s40670-020-00969-2.
- Muzyk A, Smothers ZPW, Andolsek KM, Bradner M, Bratberg JP, Clark SA, Collins K, Greskovic GA, Gruppen L, MacEachern M, Ramsey SE, Ruiz Veve J, Tetrault JM. Interprofessional Substance Use Disorder Education in Health Professions Education Programs: A Scoping Review. Academic Medicine 2020, 95: 470-480. PMID: 31651435, DOI: 10.1097/acm.0000000000003053.
- Kapo J, Blatt L, Tetrault J, Weimer M. Addiction Medicine Specialists in Your Back Pocket: Building an Essential Collaboration (FR434). Journal Of Pain And Symptom Management 2020, 59: 463-464. DOI: 10.1016/j.jpainsymman.2019.12.143.
- Oldfield BJ, Tetrault JM, Wilkins KM, Edelman EJ, Capurso NA. Opioid Overdose Prevention Education for Medical Students: Adopting Harm Reduction into Mandatory Clerkship Curricula. Substance Abuse 2020, 41: 29-34. PMID: 31211657, DOI: 10.1080/08897077.2019.1621241.
- Burnout Among Beginning First-Year Students from Three Health Professional Training ProgramRoberts, A., Angoff, N. R., Brissette, D., Dupee, D., Fahs, D., Honan, L., Korbey, S., Roessler, E., Schwartz, M., Shabanova, V., Tetrault, J., Wu, B., Colson, E., & Encandela, J. (2020). Burnout Among Beginning First-Year Students from Three Health Professional Training Programs. Medical Science Educator, 30(2), 879-883. https://doi.org/10.1007/s40670-020-00969-2
- Kansagara D, Becker WC, Ayers C, Tetrault JM. Priming primary care providers to engage in evidence-based discussions about cannabis with patients. Addiction Science & Clinical Practice 2019, 14: 42. PMID: 31787111, PMCID: PMC6886188, DOI: 10.1186/s13722-019-0171-3.
- Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2019, 171: 931-932. PMID: 31766053, DOI: 10.7326/m19-2303.
- Muzyk A, Smothers ZPW, Akrobetu D, Ruiz Veve J, MacEachern M, Tetrault JM, Gruppen L. Substance Use Disorder Education in Medical Schools: A Scoping Review. Academic Medicine 2019, 94: 1825-1834. PMID: 31663960, DOI: 10.1097/acm.0000000000002883.
- Dunne D, Green M, Tetrault J, Barakat LA. Development of a Novel Competency-Based Evaluation System for HIV Primary Care Training: the HIV Entrustable Professional Activities. Journal Of General Internal Medicine 2019, 35: 331-335. PMID: 31667752, PMCID: PMC6957645, DOI: 10.1007/s11606-019-04956-1.
- Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham CO, Ogbuagu O, Patel VV, Phillips KA, Tetrault JM, Shah M, Blackstock O. Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers. Preventive Medicine Reports 2019, 17: 101012. PMID: 31890474, PMCID: PMC6926349, DOI: 10.1016/j.pmedr.2019.101012.
- Krishnan-Sarin S, O’Malley S, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH. Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial. Neuropsychopharmacology 2019, 45: 319-326. PMID: 31590179, PMCID: PMC6901445, DOI: 10.1038/s41386-019-0536-z.
- Holt SR, Donroe JH, Cavallo DA, Tetrault JM. Corrigendum to “Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder” [Drug Alcohol Depend. 186 (2018) 171–174]. Drug And Alcohol Dependence 2019, 205: 107601. PMID: 31593815, DOI: 10.1016/j.drugalcdep.2019.107601.
- de Laat B, Goldberg A, Shi J, Tetrault JM, Nabulsi N, Zheng MQ, Najafzadeh S, Gao H, Kapinos M, Ropchan J, O'Malley SS, Huang Y, Morris ED, Krishnan-Sarin S. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving. Biological Psychiatry 2019, 86: 864-871. PMID: 31399255, DOI: 10.1016/j.biopsych.2019.05.021.
- Oldfield B, Muñoz N, McGovern M, Funaro M, Villanueva M, Tetrault J, Edelman E. Integration of care for HIV and opioid use disorder. AIDS 2019, Publish Ahead of Print: &na;. PMID: 30882491, PMCID: PMC6588508, DOI: 10.1097/qad.0000000000002125.
- Andrews J, Jones C, Tetrault J, Coontz K. Advocacy Training for Residents. Academic Medicine 2019, 94: 204-207. PMID: 30334843, DOI: 10.1097/acm.0000000000002500.
- Bernstein SL, Weiss J, DeWitt M, Tetrault JM, Hsiao AL, Dziura J, Sussman S, Miller T, Carpenter K, O’Connor P, Toll B. A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results. Implementation Science 2019, 14: 8. PMID: 30670043, PMCID: PMC6343239, DOI: 10.1186/s13012-019-0856-8.
- Edelman EJ, Tetrault JM. Unhealthy Alcohol Use in Primary Care-The Elephant in the Examination Room. JAMA Internal Medicine 2019, 179: 9-10. PMID: 30422276, DOI: 10.1001/jamainternmed.2018.6125.
- Oldfield BJ, Muñoz N, Boshnack N, Leavitt R, McGovern MP, Villanueva M, Tetrault JM, Edelman E. “No more falling through the cracks”: A qualitative study to inform measurement of integration of care of HIV and opioid use disorder. Journal Of Substance Use And Addiction Treatment 2018, 97: 28-40. PMID: 30577897, DOI: 10.1016/j.jsat.2018.11.007.
- Barakat LA, Dunne DW, Tetrault JM, Soares S, Chia D, Ogbuagu OE, Moriarty JP, Huot SJ, Green ML. The Changing Face of HIV Care. Academic Medicine 2018, 93: 1673-1678. PMID: 29901657, DOI: 10.1097/acm.0000000000002317.
- Edelman EJ, Oldfield BJ, Tetrault JM. Office-Based Addiction Treatment in Primary Care Approaches That Work. Medical Clinics Of North America 2018, 102: 635-652. PMID: 29933820, DOI: 10.1016/j.mcna.2018.02.007.
- Roberts W, Shi JM, Tetrault JM, McKee SA. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users. Journal Of Addiction Medicine 2018, 12: 227-233. PMID: 29438157, PMCID: PMC5970035, DOI: 10.1097/adm.0000000000000392.
- Verplaetse TL, Weinberger AH, Ashare RL, Pittman BP, Shi JM, Tetrault JM, Lavery M, McKee SA. Pilot investigation of the effect of carvedilol on stress-precipitated smoking-lapse behavior. Journal Of Psychopharmacology 2018, 32: 1003-1009. PMID: 29692206, PMCID: PMC6258014, DOI: 10.1177/0269881118767647.
- Donroe JH, Tetrault JM. Narrowing the treatment gap in managing opioid use disorder. Canadian Medical Association Journal 2018, 190: e236-e237. PMID: 29507154, PMCID: PMC5837871, DOI: 10.1503/cmaj.180209.
- Holt SR, Donroe JH, Cavallo DA, Tetrault JM. Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. Drug And Alcohol Dependence 2018, 186: 171-174. PMID: 29579725, DOI: 10.1016/j.drugalcdep.2017.12.040.
- Deligianni M, Tetrault J. La réduction de la consommation de cannabis améliore les résultats fonctionnels au fil du temps. Revue Médicale Suisse 2018, 14: 2184. PMID: 30484980, DOI: 10.53738/revmed.2018.14.629.2184.
- Opioid Intoxication and WithdrawalTetrault JM, O’Connor PG. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Sixth Edition. Wolters Kluwer. Philadelphia, PA. 2018. Pp 741-756.
- Tetrault JM, Fiellin DA. More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic. Annals Of Internal Medicine 2017, 168: 73-74. PMID: 29159399, DOI: 10.7326/m17-2854.
- Donroe JH, Holt SR, O’Connor P, Sukumar N, Tetrault JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug And Alcohol Dependence 2017, 180: 46-51. PMID: 28866369, DOI: 10.1016/j.drugalcdep.2017.07.040.
- Tetrault JM, Petrakis IL. Partnering with Psychiatry to Close the Education Gap: An Approach to the Addiction Epidemic. Journal Of General Internal Medicine 2017, 32: 1387-1389. PMID: 28766126, PMCID: PMC5698217, DOI: 10.1007/s11606-017-4140-9.
- Holt SR, Segar N, Cavallo DA, Tetrault JM. The Addiction Recovery Clinic. Academic Medicine 2017, 92: 680-683. PMID: 28441678, DOI: 10.1097/acm.0000000000001480.
- Donroe JH, Tetrault JM. Recognizing and Caring for the Intoxicated Patient in an Outpatient Clinic. Medical Clinics Of North America 2017, 101: 573-586. PMID: 28372714, DOI: 10.1016/j.mcna.2016.12.012.
- Verplaetse TL, Weinberger AH, Oberleitner LM, Smith KM, Pittman BP, Shi JM, Tetrault JM, Lavery ME, Picciotto MR, McKee SA. Effect of doxazosin on stress reactivity and the ability to resist smoking. Journal Of Psychopharmacology 2017, 31: 830-840. PMID: 28440105, PMCID: PMC5823502, DOI: 10.1177/0269881117699603.
- Donroe JH, Tetrault JM. Substance Use, Intoxication, and Withdrawal in the Critical Care Setting. Critical Care Clinics 2017, 33: 543-558. PMID: 28601134, DOI: 10.1016/j.ccc.2017.03.003.
- Bernstein SL, Rosner J, DeWitt M, Tetrault J, Hsiao AL, Dziura J, Sussman S, O'Connor P, Toll B. Design and implementation of decision support for tobacco dependence treatment in an inpatient electronic medical record: a randomized trial. Translational Behavioral Medicine 2017, 7: 185-195. PMID: 28194729, PMCID: PMC5526813, DOI: 10.1007/s13142-017-0470-8.
- Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.
- Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O. Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs. AIDS And Behavior 2016, 21: 1025-1033. PMID: 27896552, PMCID: PMC5344709, DOI: 10.1007/s10461-016-1612-6.
- Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. Journal Of General Internal Medicine 2016, 32: 62-70. PMID: 27778215, PMCID: PMC5215171, DOI: 10.1007/s11606-016-3903-z.
- Donroe JH, Holt SR, Tetrault JM. Caring for patients with opioid use disorder in the hospitalCaring for patients with opioid use disorder in the hospital. Canadian Medical Association Journal 2016, 188: cmaj.160290. PMID: 27647616, PMCID: PMC5135493, DOI: 10.1503/cmaj.160290.
- Chambers D, Simpson L, Hill-Briggs F, Neta G, Vinson C, Chambers D, Beidas R, Marcus S, Aarons G, Hoagwood K, Schoenwald S, Evans A, Hurford M, Rubin R, Hadley T, Barg F, Walsh L, Adams D, Mandell D, Martin L, Mignogna J, Mott J, Hundt N, Kauth M, Kunik M, Naik A, Cully J, McGuire A, White D, Bartholomew T, McGrew J, Luther L, Rollins A, Salyers M, Cooper B, Funaiole A, Richards J, Lee A, Lapham G, Caldeiro R, Lozano P, Gildred T, Achtmeyer C, Ludman E, Addis M, Marx L, Bradley K, VanDeinse T, Wilson A, Stacey B, Powell B, Bunger A, Cuddeback G, Barnett M, Stadnick N, Brookman-Frazee L, Lau A, Dorsey S, Pullmann M, Mitchell S, Schwartz R, Kirk A, Dusek K, Oros M, Hosler C, Gryczynski J, Barbosa C, Dunlap L, Lounsbury D, O’Grady K, Brown B, Damschroder L, Waltz T, Powell B, Ritchie M, Waltz T, Atkins D, Imel Z, Xiao B, Can D, Georgiou P, Narayanan S, Berkel C, Gallo C, Sandler I, Brown C, Wolchik S, Mauricio A, Gallo C, Brown C, Mehrotra S, Chandurkar D, Bora S, Das A, Tripathi A, Saggurti N, Raj A, Hughes E, Jacobs B, Kirkendall E, Loeb D, Trinkley K, Yang M, Sprowell A, Nease D, Lyon A, Lewis C, Boyd M, Melvin A, Nicodimos S, Liu F, Jungbluth N, Lyon A, Lewis C, Boyd M, Melvin A, Nicodimos S, Liu F, Jungbluth N, Flynn A, Landis-Lewis Z, Sales A, Baloh J, Ward M, Zhu X, Bennett I, Unutzer J, Mao J, Proctor E, Vredevoogd M, Chan Y, Williams N, Green P, Bernstein S, Rosner J, DeWitt M, Tetrault J, Dziura J, Hsiao A, Sussman S, O’Connor P, Toll B, Jones M, Gassaway J, Tobin J, Zatzick D, Bradbury A, Patrick-Miller L, Egleston B, Olopade O, Hall M, Daly M, Fleisher L, Grana G, Ganschow P, Fetzer D, Brandt A, Farengo-Clark D, Forman A, Gaber R, Gulden C, Horte J, Long J, Chambers R, Lucas T, Madaan S, Mattie K, McKenna D, Montgomery S, Nielsen S, Powers J, Rainey K, Rybak C, Savage M, Seelaus C, Stoll J, Stopfer J, Yao S, Domchek S, Hahn E, Munoz-Plaza C, Wang J, Delgadillo J, Mittman B, Gould M, Liang S, Kegler M, Cotter M, Phillips E, Hermstad A, Morton R, Beasley D, Martinez J, Riehman K, Gustafson D, Marsch L, Mares L, Quanbeck A, McTavish F, McDowell H, Brown R, Thomas C, Glass J, Isham J, Shah D, Liebschutz J, Lasser K, Watkins K, Ober A, Hunter S, Lamp K, Ewing B, Iwelunmor J, Gyamfi J, Blackstone S, Quakyi N, Plange-Rhule J, Ogedegbe G, Kumar P, Van Devanter N, Nguyen N, Nguyen L, Nguyen T, Phuong N, Shelley D, Rudge S, Langlois E, Tricco A, Ball S, Lambert-Kerzner A, Sulc C, Simmons C, Shell-Boyd J, Oestreich T, O’Connor A, Neely E, McCreight M, Labebue A, DiFiore D, Brostow D, Ho P, Aron D, Harvey J, McHugh M, Scanlon D, Lee R, Soltero E, Parker N, McNeill L, Ledoux T, McIsaac J, MacLeod K, Ata N, Jarvis S, Kirk S, Purtle J, Dodson E, Brownson R, Mittman B, Curran G, Curran G, Pyne J, Aarons G, Ehrhart M, Torres E, Miech E, Miech E, Stevens K, I.S.R.N. Steering Council, Hamilton A, Cohen D, Padgett D, Morshed A, Patel R, Prusaczyk B, Aron D, Gupta D, Ball S, Hand R, Abram J, Wolfram T, Hastings M, Moreland-Russell S, Tabak R, Ramsey A, Baumann A, Kryzer E, Montgomery K, Lewis E, Padek M, Powell B, Brownson R, Mamaril C, Mays G, Branham K, Timsina L, Mays G, Hogg R, Fagan A, Shapiro V, Brown E, Haggerty K, Hawkins D, Oesterle S, Hawkins D, Catalano R, McKay V, Dolcini M, Hoffer L, Moin T, Li J, Duru O, Ettner S, Turk N, Chan C, Keckhafer A, Luchs R, Ho S, Mangione C, Selby P, Zawertailo L, Minian N, Balliunas D, Dragonetti R, Hussain S, Lecce J, Chinman M, Acosta J, Ebener P, Malone P, Slaughter M, Freedman D, Flocke S, Lee E, Matlack K, Trapl E, Ohri-Vachaspati P, Taggart M, Borawski E, Parrish A, Harris J, Kohn M, Hammerback K, McMillan B, Hannon P, Swindle T, Curran G, Whiteside-Mansell L, Ward W, Holt C, Santos S, Tagai E, Scheirer M, Carter R, Bowie J, Haider M, Slade J, Wang M, Masica A, Ogola G, Berryman C, Richter K, Shelton R, Jandorf L, Erwin D, Truong K, Javier J, Coffey D, Schrager S, Palinkas L, Miranda J, Johnson V, Hutcherson V, Ellis R, Kharmats A, Marshall-King S, LaPradd M, Fonseca-Becker F, Kepka D, Bodson J, Warner E, Fowler B, Shenkman E, Hogan W, Odedina F, De Leon J, Hooper M, Carrasquillo O, Reams R, Hurt M, Smith S, Szapocznik J, Nelson D, Mandal P, Teufel J. Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation. Implementation Science 2016, 11: 100. PMID: 27490260, PMCID: PMC4977475, DOI: 10.1186/s13012-016-0452-0.
- Holt S, Tetrault J. Unhealthy Alcohol Use. Clinics In Liver Disease 2016, 20: 429-444. PMID: 27373607, DOI: 10.1016/j.cld.2016.02.003.
- Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal Of Substance Use And Addiction Treatment 2016, 68: 62-67. PMID: 27431048, PMCID: PMC4976086, DOI: 10.1016/j.jsat.2016.06.002.
- Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA. Effect of Varenicline Combined with High‐Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings. Alcohol Clinical And Experimental Research 2016, 40: 1567-1576. PMID: 27246567, PMCID: PMC4930423, DOI: 10.1111/acer.13110.
- Becker WC, Tetrault JM. Medical Marijuana in Patients Prescribed Opioids A Cloud of Uncertainty. Mayo Clinic Proceedings 2016, 91: 830-832. PMID: 27234481, DOI: 10.1016/j.mayocp.2016.04.008.
- Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA. Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders. Journal Of Addiction Medicine 2016, 10: 166-173. PMID: 27159341, PMCID: PMC4880525, DOI: 10.1097/adm.0000000000000208.
- Ambulatory management of alcohol withdrawal syndromeHolt SR, Tetrault JM. Ambulatory management of alcohol withdrawal syndrome. UpToDate topic. 2016. Updated Nov 30, 2017
- Tetrault JM, Butner JL. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review. The Yale Journal Of Biology And Medicine 2015, 88: 227-33. PMID: 26339205, PMCID: PMC4553642.
- Opioid agonist treatment considerations in HIV-infected and HIV/HCV co-infected patientsInternational AIDS Society Cases on the Web Activity. October 21, 2015, Updated November 1, 2016
- Tetrault JM, McCance-Katz EF, Moody DE, Fiellin DA, Lruie BS, DInh AT, Fiellin LE. The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection. Journal Of Substance Use And Addiction Treatment 2014, 51: 70-74. PMID: 25480096, DOI: 10.1016/j.jsat.2014.10.010.
- Edelman EJ, Tetrault JM, Fiellin DA. Substance use in older HIV-infected patients. Current Opinion In HIV And AIDS 2014, 9: 317-324. PMID: 24824888, PMCID: PMC4175926, DOI: 10.1097/coh.0000000000000069.
- Galbrun G, Tetrault J. Le [i]binge drinking[/i] chez les jeunes adultes en bonne santé augmente le risque de maladies cardio-vasculaires. Revue Médicale Suisse 2014, 10: 725-725. DOI: 10.53738/revmed.2014.10.423.0725.
- Opioid Intoxication and WithdrawalTetrault JM, O'Connor. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Fifth Edition. Wolters Kluwer. Philadelphia, PA. 2014. Pp 668-685.
- Unhealthy alcohol use, including alcohol use disorderTetrault JM, O'Connor PG. Unhealthy alcohol use, including alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course assessment, and diagnosis. UpToDate Topic. December, 2014. Updated Sept 13, 2018.
- Ebert S, Tetrault J. Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers. Revue Médicale Suisse 2014, 10: 1893. PMID: 25417365, DOI: 10.53738/revmed.2014.10.445.1893.
- Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, Walley AY. 2013 Update in addiction medicine for the generalist. Addiction Science & Clinical Practice 2013, 8: 18. PMID: 24499640, PMCID: PMC3819258, DOI: 10.1186/1940-0640-8-18.
- Becker WC, Meghani S, Tetrault JM, Fiellin DA. Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S. American Journal On Addictions 2013, 23: 357-362. PMID: 24112118, DOI: 10.1111/j.1521-0391.2013.12109.x.
- Udo T, Harrison EL, Shi J, Tetrault J, McKee SA. A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration. American Journal On Addictions 2013, 22: 590-597. PMID: 24131167, PMCID: PMC3934424, DOI: 10.1111/j.1521-0391.2013.12014.x.
- Rastegar DA, Kunins HV, Tetrault JM, Walley AY, Gordon AJ, For the US Society of General Internal Medicine’s Substance Abuse Interest Group. 2012 Update in addiction medicine for the generalist. Addiction Science & Clinical Practice 2013, 8: 6. PMID: 23497615, PMCID: PMC3602093, DOI: 10.1186/1940-0640-8-6.
- Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA. Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment. Journal Of Addiction Medicine 2013, 7: 102-107. PMID: 23388678, PMCID: PMC3618545, DOI: 10.1097/adm.0b013e31827f9bdf.
- Walley AY, Tetrault JM, Friedmann PD. Integration of substance use treatment and medical care: A special issue of JSAT. Journal Of Substance Use And Addiction Treatment 2012, 43: 377-381. PMID: 23079197, DOI: 10.1016/j.jsat.2012.09.002.
- Ryan S, Martel S, Pantalon M, Martino S, Tetrault J, Thung S, Bernstein S, Auinger P, D’Onofrio G. Screening, brief intervention, and referral to treatment for alcohol and other drug use among adolescents: evaluation of a pediatric residency curriculum. Addiction Science & Clinical Practice 2012, 7: a98. PMCID: PMC3480164, DOI: 10.1186/1940-0640-7-s1-a98.
- Holt SR, Ramos J, Harma M, Cabrera F, Louis-Ashby C, Dinh A, Fiellin DA, Tetrault JM. Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical Services. The American Journal Of Drug And Alcohol Abuse 2012, 39: 121-129. PMID: 22992028, DOI: 10.3109/00952990.2012.715703.
- Tetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal Of Substance Use And Addiction Treatment 2012, 43: 433-439. PMID: 22938914, DOI: 10.1016/j.jsat.2012.07.011.
- Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous Use of Alcohol, Cigarettes, and Marijuana and Subsequent Abuse of Prescription Opioids in Young Adults. Journal Of Adolescent Health 2012, 52: 158-163. PMID: 23332479, PMCID: PMC3552239, DOI: 10.1016/j.jadohealth.2012.06.010.
- Edelman EJ, Dinh A, Radulescu R, Lurie B, D'Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE. Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot Study. The American Journal Of Drug And Alcohol Abuse 2012, 38: 539-543. PMID: 22794939, PMCID: PMC3522092, DOI: 10.3109/00952990.2012.701359.
- Ryan SA, Martel S, Pantalon M, Martino S, Tetrault J, Thung SF, Bernstein SL, Auinger P, Green ML, Fiellin DA, O'Connor P, D'Onofrio G. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency Curriculum. Substance Abuse 2012, 33: 251-260. PMID: 22738002, DOI: 10.1080/08897077.2011.640182.
- McKee SA, Weinberger AH, Shi J, Tetrault J, Coppola S. Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation. Nicotine & Tobacco Research 2012, 14: 1362-1371. PMID: 22492085, PMCID: PMC3482010, DOI: 10.1093/ntr/nts090.
- Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor P, Fiellin DA, D'Onofrio G. Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Substance Abuse 2012, 33: 168-181. PMID: 22489589, DOI: 10.1080/08897077.2011.640220.
- Holt SR, Ramos J, Harma MA, Cabrera F, Louis‐Ashby C, Dinh A, Tetrault JM, Fiellin DA. Prevalence of Unhealthy Substance Use on Teaching and Hospitalist Medical Services: Implications for Education. American Journal On Addictions 2012, 21: 111-119. PMID: 22332853, DOI: 10.1111/j.1521-0391.2011.00207.x.
- Tetrault JM, Fiellin DA. Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 2012, 72: 217-228. PMID: 22235870, PMCID: PMC3701303, DOI: 10.2165/11597520-000000000-00000.
- Tetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K, Justice AC, Fiellin DA, Team F. Hepatic Safety and Antiretroviral Effectiveness in HIV‐Infected Patients Receiving Naltrexone. Alcohol Clinical And Experimental Research 2011, 36: 318-324. PMID: 21797892, PMCID: PMC3221963, DOI: 10.1111/j.1530-0277.2011.01601.x.
- Sullivan LE, Tetrault JM, Braithwaite RS, Turner BJ, Fiellin DA. A Meta‐analysis of the Efficacy of Nonphysician Brief Interventions for Unhealthy Alcohol Use: Implications for the Patient‐Centered Medical Home. American Journal On Addictions 2011, 20: 343-356. PMID: 21679266, DOI: 10.1111/j.1521-0391.2011.00143.x.
- Tetrault JM, Fiellin DA. Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults. BMJ Mental Health 2011, 14: 30. PMID: 21266627, DOI: 10.1136/ebmh.14.1.30.
- . Medical Management in Handbook of Office Based Buprenorphine for Opioid DependenceTetrault JM, Sullivan LE, Fiellin DA, Medical Management in Handbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Medical Management in Handbook of Office Based Buprenorphine for Opioid DependenceTetrault JM, Sullivan LE, Fiellin DA. Medical Management in Handbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Medical Management in Treatment of Opioid Used DisorderHandbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Tetrault JM, Fiellin DA, Niccolai LM, Sullivan LE. Substance Use in Patients with Sexually Transmitted Infections: Results from a National U.S. Survey. American Journal On Addictions 2010, 19: 504-509. PMID: 20958845, DOI: 10.1111/j.1521-0391.2010.00087.x.
- Gordon AJ, Kunins HV, Rastegar DA, Tetrault JM, Walley AY. Update in Addiction Medicine for the Generalist. Journal Of General Internal Medicine 2010, 26: 77-82. PMID: 20697971, PMCID: PMC3024103, DOI: 10.1007/s11606-010-1461-3.
- Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Opioids, Chronic Pain, and Addiction in Primary Care. Journal Of Pain 2010, 11: 1442-1450. PMID: 20627817, PMCID: PMC2955997, DOI: 10.1016/j.jpain.2010.04.002.
- Gaume J, Tetrault J. Alcool et risques cardiovasculaires chez des hommes infectés ou non par le VIH. Revue Médicale Suisse 2010, 6: 2046a-2046a. DOI: 10.53738/revmed.2010.6.268.2046a.
- Substance Use and HIVTetrault JM, Fiellin DA, Sullivan LE. Substance Use and HIV: Treatment Challenges. The AIDS Reader 2019, Vol. No. August 3, 2010
- McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E. Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers. Biological Psychiatry 2009, 66: 185-190. PMID: 19249750, PMCID: PMC2863311, DOI: 10.1016/j.biopsych.2009.01.029.
- Opioid Intoxication and WithdrawalTetrault JM, O'Connor PG. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Fourth Edition. Lippincott, Williams & Wilkins, Inc. Philadelphia, PA 2009, Pp 589-603.
- Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor P, Schottenfeld RS, Fiellin DA. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal Of General Internal Medicine 2008, 24: 218-225. PMID: 19089500, PMCID: PMC2628993, DOI: 10.1007/s11606-008-0881-9.
- Tetrault JM, Sauler M, Wells CK, Concato J. Reporting of Multivariable Methods in the Medical Literature. Journal Of Investigative Medicine 2008, 56: 954. PMID: 18797413, DOI: 10.2310/jim.0b013e31818914ff.
- Tetrault J, Sauler M, Wells C, Concato J. Reporting of Multivariable Methods in the Medical Literature. Journal Of Investigative Medicine 2008, 56: 954. DOI: 10.231/jim.0b013e31818914ff.
- Tetrault JM, O'Connor PG. Substance Abuse and Withdrawal in the Critical Care Setting. Critical Care Clinics 2008, 24: 767-788. PMID: 18929942, DOI: 10.1016/j.ccc.2008.05.005.
- Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug And Alcohol Dependence 2007, 94: 38-47. PMID: 18063321, DOI: 10.1016/j.drugalcdep.2007.09.018.
- Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non‐medical use of prescription opioids: results from a national US survey*. Addiction 2007, 103: 258-268. PMID: 18042194, DOI: 10.1111/j.1360-0443.2007.02056.x.
- Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review. JAMA Internal Medicine 2007, 167: 221-228. PMID: 17296876, PMCID: PMC2720277, DOI: 10.1001/archinte.167.3.221.
- What are the pulmonary effects of smoking marijuana?Tetrault JM, Crothers K. Clinical update: What are the pulmonary effects of smoking marijuana? The Journal of Respiratory Diseases. 2007, 28(6):253-254
- Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.
- Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of LiteratureKansagara DL, Tetrault J, Hamill C, Moore C, Olson B. Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature. Endocrine Practice 2006, 12: 651-655. PMID: 17229661, DOI: 10.4158/ep.12.6.651.
- Sullivan LE, Tetrault J, Bangalore D, Fiellin DA. Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence. Substance Abuse 2006, 27: 13-18. PMID: 17135176, DOI: 10.1300/j465v27n03_03.
- Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The Association Between Marijuana Smoking and Lung Cancer: A Systematic Review. JAMA Internal Medicine 2006, 166: 1359-1367. PMID: 16832000, DOI: 10.1001/archinte.166.13.1359.
Departments and Programs
Locations
1
1 of 2
- Addiction Recovery ClinicDana Clinic Building789 Howard AvenueNew Haven, CT 06519
- APT Foundation1 Long Wharf DriveNew Haven, CT 06511
Biography
Jeanette M. Tetrault, MD, is an attending physician at Yale New Haven Hospital who also provides primary care and substance use disorder treatment at the central medical unit of the APT Foundation in New Haven, a multi-specialty addiction treatment facility that is affiliated with Yale New Haven Hospital. She focuses on patients with addiction and medical issues associated with substance use, including HIV and Hepatitis C
“I am dedicated to caring for patients from underserved communities,” says Dr. Tetrault, an associate professor of medicine (general medicine) at Yale School of Medicine. “Our nation currently faces a health care crisis related to opioid addiction, and I am pleased to provide nonjudgmental, evidence-based treatment to patients and families struggling with this chronic medical condition.”
As a researcher, Dr. Tetrault has published widely in the field of Addiction Medicine, including epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmacotherapies, and addiction medicine curriculum design, evaluation, and dissemination.
Titles
- Professor of Medicine (General Medicine)
- Program Director, Addiction Medicine Fellowship, Internal Medicine
- Academic Advisor, Office of Student Affairs
- Associate Director for Education and Training, Program in Addiction Medicine, Internal Medicine
- Vice-chief for Education, General Internal Medicine
- Professor, Chronic Disease Epidemiology
Education & Training
- Ambulatory Care FellowWest Haven VA Hospital (2007)
- Chief ResidentYale School of Medicine (2005)
- Medical Intern and ResidentYale School of Medicine (2004)
- MDBoston University School of Medicine (2001)
- BABoston University, Biology (1997)
Additional Information
Honors & Recognitions
- John P. McGovern Award for Excellence in Medical Education: Association for Multidisciplinary Education and Research in Substance Use and Addiction (2023)
- Annual Training Directors Award: American Society of Addiction Medicine (2021)
- Elected as President : American College of Academic Addiction Medicine (2019)
- Awarded W. Anderson Spickard Excellence in Mentorship Award: Association for Multidisciplinary Education and Research in Substance Use and Addiction (2018)
- Recognized Macy Foundation Faculty Scholar: Macy Foundation (2017)
- Elected as Milestones Committee Chair: The Addiction Medicine Foundation (2017)
- Elected President: Society of General Internal Medicine, New England Region (2014)
- Clinician Educator of the Year: Society of General Internal Medicine-New England Regional Award for Excellence (2013)
- George Thornton Community Teacher of the Year Award: Yale School of Medicine Primary Care Internal Medicine Residency Program (2011)
- Selected as Co-chair Alcohol, Tobacco, and Other Drug Use Interest Group: Society of General Internal Medicine (2011)
Board Certifications
- AB of Preventive Medicine, Addiction Medicine (2018)
Professional Service
- Yale New Haven Hospital-Ambulatory treatment of OUD pathway Committee (2022 - Present): Serve as a member of the YNHH ambulatory treatment of OUD pathway committee
- Yale School of Medicine-Medical Student Subcommittee of LCME Self Study (2022 - Present): Member of the medical student subcommittee of the YSM LCME Self Study Task Force
- Curbsiders Addiction Medicine Podcast (2022 - Present): Invited speaker for podcast focusing on decreasing stigma in addiction medicine
- American College of Academic Addiction Medicine (2022 - Present): President
- YSM-YNHH Addiction Medicine/Addiction Psychiatry Services Steering Committee (2021 - Present): Member
- NPR (2021 - Present): Invited guest on CT Public Radio to discuss alcohol use disorder in women
- Accreditation Council for Continuing Medical Education, Independent Grant Review Committee (2021 - 2023): Served as grant reviewer for REMS Program Companies that make and market opioids to provide commercial support to accredited continuing education for healthcare teams to promote safe prescribing and help combat the opioid crisis. Served in 2021 and 2022
- University of Washington (2020 - 2022): Serve as Independent Safety Monitor for NIDA Funded R34 (PI Judith Tsui, MD; University of Washington) pilot study of community pharmacy model for treating people who inject drugs who are infected with Hepatitis C
- American College of Academic Addiction Medicine (2019 - 2022): President-elect
- American College of Academic Addiction Medicine (2019 - Present): Chair, ACGME Milestones subcommittee
Publications
- Miller S, Levy S, Saxon A, Tetrault J, Rosenthal R, Wakeman S, Vocci F. Revisiting Preaddiction. Journal Of Addiction Medicine 2024 DOI: 10.1097/adm.0000000000001357.
- Haque L, Fiellin D, Bryant K, Edelman E, Justice A, Lim J, Re V, Marshall B, Taddei T, Tate J, Tetrault J, Williams E, McGinnis K. W31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis. Drug And Alcohol Dependence 2024, 260: 110649. DOI: 10.1016/j.drugalcdep.2023.110649.
- Mahoney B, Morford K, Biegacki E, Tetrault J. Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease 2024, 23: e0241. PMID: 38952692, PMCID: PMC11216679, DOI: 10.1097/cld.0000000000000241.
- Abdulfattah S, Ahmad A, Kitaneh R, Alsharaydeh T, Almudallal F, Alzoubi R, Abbadi R, Haddad T, Wazaify M, Alkayed Z, Mustafa R, Tetrault J. Nonmedical Use of Stimulants Among Students in Jordan: A Nationwide Study. Journal Of Addiction Medicine 2024, 18: 443-450. PMID: 38587298, DOI: 10.1097/adm.0000000000001308.
- Cavallo D, Salwan J, Doernberg M, Tetrault J, Holt S. Shared Medical Appointment: A Novel Model for Incorporating Group Visits Into Residency Training for Substance Use Disorders. Substance Use & Addiction Journal 2024, 45: 466-472. PMID: 38494709, DOI: 10.1177/29767342241233363.
- Morford K, Tetrault J, Fiellin D. The MATE Act: Progress for substance use education, but is checking a box enough? Journal Of General Internal Medicine 2024, 39: 1496-1498. PMID: 38308156, PMCID: PMC11169132, DOI: 10.1007/s11606-024-08652-7.
- Canver B, Liptak A, Clark K, Tetrault J, Holt S. Preparing Physicians to Treat Addiction: Inclusion of Dedicated Addiction Training During Internal Medicine Residency. Substance Use & Addiction Journal 2024, 45: 408-414. PMID: 38254274, DOI: 10.1177/29767342231224978.
- Kazemitabar M, Nyhan K, Makableh N, Minahan-Rowley R, Ali M, Wazaify M, Tetrault J, Khoshnood K. Epidemiology of substance use and mental health disorders among forced migrants displaced from the MENAT region: A systematic review and meta-analysis protocol. PLOS ONE 2023, 18: e0292535. PMID: 37797050, PMCID: PMC10553213, DOI: 10.1371/journal.pone.0292535.
- Entrup P, Brodsky L, Trimble C, Garcia S, Mohamed N, Deaner M, Martell J, Teater J, Jordan A, Tetrault J, Hall O. Years of life lost due to deaths of despair and COVID-19 in the United States in 2020: patterns of excess mortality by gender, race and ethnicity. International Journal For Equity In Health 2023, 22: 161. PMID: 37612748, PMCID: PMC10464324, DOI: 10.1186/s12939-023-01949-9.
- Huxley‐Reicher Z, Puglisi L, Tetrault J, Weimer M, Stellini M, Bhandary‐Alexander J, Thomas K, Donroe J. Response to substance use during hospitalization: A survey study of current and ideal policies and practices. Journal Of Hospital Medicine 2023, 18: 829-834. PMID: 37475186, DOI: 10.1002/jhm.13162.
- Brooks R, Wegener M, Freeman B, Fowles C, Madden L, Tetrault J, Nichols L, Altice F, Villanueva M. Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches. Health Promotion Practice 2023, 24: 1018-1028. PMID: 37439759, DOI: 10.1177/15248399231169791.
- Chan C, Tetrault J, Holt S. Leading a Substance Use Disorder Clinic. 2023, 255-274. DOI: 10.1007/978-3-031-40273-9_17.
- Haque L, Fiellin D, Tate J, Esserman D, Bhattacharya D, Butt A, Crystal S, Edelman E, Gordon A, Lim J, Tetrault J, Williams E, Bryant K, Cartwright E, Rentsch C, Justice A, Re V, McGinnis K. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. JAMA Network Open 2022, 5: e2246604. PMID: 36515952, PMCID: PMC9856353, DOI: 10.1001/jamanetworkopen.2022.46604.
- Morford K, Tetrault J, Zhou B, Li F, Gleeson B, Edelman E, Stein M, Barry D, Madden L. The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study. Drug And Alcohol Dependence 2022, 241: 109707. PMID: 36423462, PMCID: PMC9777057, DOI: 10.1016/j.drugalcdep.2022.109707.
- Morford KL, Batchelor HM, Tetrault JM. Grief at the Heart of the Opioid Overdose Crisis: Past Lessons and Present Implications. Journal Of Addiction Medicine 2022, 16: 613-615. PMID: 35165230, DOI: 10.1097/adm.0000000000000976.
- Barcelona V, Wischik DL, Marshall A, Tetrault JM. Integration of medication for opioid use disorder training into graduate nursing education. Nursing Forum 2022, 57: 869-873. PMID: 35616353, DOI: 10.1111/nuf.12753.
- Haque LY, Butner JL, Shi JM, Henry S, Deng Y, Ciarleglio MM, Madden LM, Tetrault JM. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting. Journal Of Addiction Medicine 2022, 16: 333-339. PMID: 34483278, PMCID: PMC9033626, DOI: 10.1097/adm.0000000000000910.
- Viera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection. Drug And Alcohol Dependence Reports 2022, 3: 100038. PMID: 36845980, PMCID: PMC9948939, DOI: 10.1016/j.dadr.2022.100038.
- Shi J, Slocum B, Tetrault J, Yanagisawa K. Chapter 9 Addiction management in the outpatient setting. 2022, 169-187. DOI: 10.1016/b978-0-323-79016-1.00008-8.
- Biegacki ET, Tetrault JM, Fiellin DA. Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine. Substance Abuse 2022, 43: 1215-1220. PMID: 35657646, DOI: 10.1080/08897077.2022.2074606.
- Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL. Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach. Journal Of Addiction Medicine 2021, 16: 399-406. PMID: 34954746, DOI: 10.1097/adm.0000000000000945.
- Du CX, Shi J, Tetrault JM, Madden LM, Barry DT. Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine. Family Practice 2021, 39: 234-240. PMID: 34893825, PMCID: PMC8947790, DOI: 10.1093/fampra/cmab166.
- Morford K, Falker C, Tetrault J. Training Medical Students, Residents, and Fellows in Opioid Use Disorder Treatment. 2021, 161-171. DOI: 10.1007/978-3-030-80818-1_11.
- Thompson SL, Gianessi CA, O'Malley SS, Cavallo DA, Shi JM, Tetrault JM, DeMartini KS, Gueorguieva R, Pittman B, Krystal JH, Taylor JR, Krishnan-Sarin S. Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants. Frontiers In Psychiatry 2021, 12: 709559. PMID: 34531767, PMCID: PMC8438169, DOI: 10.3389/fpsyt.2021.709559.
- Chan CA, Tetrault JM, Fiellin DA, Weimer MB. SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures Act. Journal Of Addiction Medicine 2021, 16: 141-142. PMID: 34049315, DOI: 10.1097/adm.0000000000000879.
- Oldfield BJ, Tetrault JM, Berland G. Addiction Screening—The A Star Is Born Movie Series and Destigmatization of Substance Use Disorders. JAMA 2021, 325: 915-917. PMID: 33687448, DOI: 10.1001/jama.2020.25256.
- Smetana GW, Tetrault JM, Hill KP, Burns RB. Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals Of Internal Medicine 2021, 174: 237-246. PMID: 33556279, DOI: 10.7326/m20-7945.
- Bisio C, Tetrault J. Association entre l’usage de cannabis et les principales anomalies congénitales. Revue Médicale Suisse 2021, 17: 1334. PMID: 34264039, DOI: 10.53738/revmed.2021.17.745.1334.
- Training medical students, residents, and fellows in opioid use disorder treatmentMorford, KL, Falker CG, Tetrault, JM. in Treating Opioid Use Disorder in General Medical Settings. Editor, Wakeman, SE.
- Treatment of Opioid Use DisorderRobinson, D and Tetrault JM. Treatment of Opioid Use Disorder in Pocket Medicine. Editor: Wakeman, SE
- Muvvala SB, Schwartz ML, Petrakis I, O'Connor P, Tetrault JM. Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical Training. Substance Abuse 2020, 41: 475-479. PMID: 31951809, DOI: 10.1080/08897077.2019.1709606.
- Severe B, Tetrault JM, Madden L, Heimer R. Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention. Drug And Alcohol Dependence 2020, 213: 108116. PMID: 32599493, DOI: 10.1016/j.drugalcdep.2020.108116.
- Haque LY, Jakab S, Deng Y, Ciarleglio MM, Tetrault JM. Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. Journal Of Addiction Medicine 2020, 14: e337-e343. PMID: 32530887, PMCID: PMC9033633, DOI: 10.1097/adm.0000000000000677.
- Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2020, 172: 774-775. PMID: 32479150, DOI: 10.7326/l20-0084.
- Tetrault JM, Holt SR, Cavallo DA, O'Connor PG, Gordon MA, Corvino JK, Nich C, Carroll KM. Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT. Journal Of Addiction Medicine 2020, 14: e303-e309. PMID: 32371660, DOI: 10.1097/adm.0000000000000663.
- Roberts A, Angoff NR, Brissette D, Dupee D, Fahs D, Honan L, Korbey S, Roessler E, Schwartz M, Shabanova V, Tetrault J, Wu B, Colson E, Encandela J. Burnout Among Beginning First-Year Students from Three Health Professional Training Programs. Medical Science Educator 2020, 30: 879-883. PMID: 34457745, PMCID: PMC8368543, DOI: 10.1007/s40670-020-00969-2.
- Muzyk A, Smothers ZPW, Andolsek KM, Bradner M, Bratberg JP, Clark SA, Collins K, Greskovic GA, Gruppen L, MacEachern M, Ramsey SE, Ruiz Veve J, Tetrault JM. Interprofessional Substance Use Disorder Education in Health Professions Education Programs: A Scoping Review. Academic Medicine 2020, 95: 470-480. PMID: 31651435, DOI: 10.1097/acm.0000000000003053.
- Kapo J, Blatt L, Tetrault J, Weimer M. Addiction Medicine Specialists in Your Back Pocket: Building an Essential Collaboration (FR434). Journal Of Pain And Symptom Management 2020, 59: 463-464. DOI: 10.1016/j.jpainsymman.2019.12.143.
- Oldfield BJ, Tetrault JM, Wilkins KM, Edelman EJ, Capurso NA. Opioid Overdose Prevention Education for Medical Students: Adopting Harm Reduction into Mandatory Clerkship Curricula. Substance Abuse 2020, 41: 29-34. PMID: 31211657, DOI: 10.1080/08897077.2019.1621241.
- Burnout Among Beginning First-Year Students from Three Health Professional Training ProgramRoberts, A., Angoff, N. R., Brissette, D., Dupee, D., Fahs, D., Honan, L., Korbey, S., Roessler, E., Schwartz, M., Shabanova, V., Tetrault, J., Wu, B., Colson, E., & Encandela, J. (2020). Burnout Among Beginning First-Year Students from Three Health Professional Training Programs. Medical Science Educator, 30(2), 879-883. https://doi.org/10.1007/s40670-020-00969-2
- Kansagara D, Becker WC, Ayers C, Tetrault JM. Priming primary care providers to engage in evidence-based discussions about cannabis with patients. Addiction Science & Clinical Practice 2019, 14: 42. PMID: 31787111, PMCID: PMC6886188, DOI: 10.1186/s13722-019-0171-3.
- Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2019, 171: 931-932. PMID: 31766053, DOI: 10.7326/m19-2303.
- Muzyk A, Smothers ZPW, Akrobetu D, Ruiz Veve J, MacEachern M, Tetrault JM, Gruppen L. Substance Use Disorder Education in Medical Schools: A Scoping Review. Academic Medicine 2019, 94: 1825-1834. PMID: 31663960, DOI: 10.1097/acm.0000000000002883.
- Dunne D, Green M, Tetrault J, Barakat LA. Development of a Novel Competency-Based Evaluation System for HIV Primary Care Training: the HIV Entrustable Professional Activities. Journal Of General Internal Medicine 2019, 35: 331-335. PMID: 31667752, PMCID: PMC6957645, DOI: 10.1007/s11606-019-04956-1.
- Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham CO, Ogbuagu O, Patel VV, Phillips KA, Tetrault JM, Shah M, Blackstock O. Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers. Preventive Medicine Reports 2019, 17: 101012. PMID: 31890474, PMCID: PMC6926349, DOI: 10.1016/j.pmedr.2019.101012.
- Krishnan-Sarin S, O’Malley S, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH. Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial. Neuropsychopharmacology 2019, 45: 319-326. PMID: 31590179, PMCID: PMC6901445, DOI: 10.1038/s41386-019-0536-z.
- Holt SR, Donroe JH, Cavallo DA, Tetrault JM. Corrigendum to “Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder” [Drug Alcohol Depend. 186 (2018) 171–174]. Drug And Alcohol Dependence 2019, 205: 107601. PMID: 31593815, DOI: 10.1016/j.drugalcdep.2019.107601.
- de Laat B, Goldberg A, Shi J, Tetrault JM, Nabulsi N, Zheng MQ, Najafzadeh S, Gao H, Kapinos M, Ropchan J, O'Malley SS, Huang Y, Morris ED, Krishnan-Sarin S. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving. Biological Psychiatry 2019, 86: 864-871. PMID: 31399255, DOI: 10.1016/j.biopsych.2019.05.021.
- Oldfield B, Muñoz N, McGovern M, Funaro M, Villanueva M, Tetrault J, Edelman E. Integration of care for HIV and opioid use disorder. AIDS 2019, Publish Ahead of Print: &na;. PMID: 30882491, PMCID: PMC6588508, DOI: 10.1097/qad.0000000000002125.
- Andrews J, Jones C, Tetrault J, Coontz K. Advocacy Training for Residents. Academic Medicine 2019, 94: 204-207. PMID: 30334843, DOI: 10.1097/acm.0000000000002500.
- Bernstein SL, Weiss J, DeWitt M, Tetrault JM, Hsiao AL, Dziura J, Sussman S, Miller T, Carpenter K, O’Connor P, Toll B. A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results. Implementation Science 2019, 14: 8. PMID: 30670043, PMCID: PMC6343239, DOI: 10.1186/s13012-019-0856-8.
- Edelman EJ, Tetrault JM. Unhealthy Alcohol Use in Primary Care-The Elephant in the Examination Room. JAMA Internal Medicine 2019, 179: 9-10. PMID: 30422276, DOI: 10.1001/jamainternmed.2018.6125.
- Oldfield BJ, Muñoz N, Boshnack N, Leavitt R, McGovern MP, Villanueva M, Tetrault JM, Edelman E. “No more falling through the cracks”: A qualitative study to inform measurement of integration of care of HIV and opioid use disorder. Journal Of Substance Use And Addiction Treatment 2018, 97: 28-40. PMID: 30577897, DOI: 10.1016/j.jsat.2018.11.007.
- Barakat LA, Dunne DW, Tetrault JM, Soares S, Chia D, Ogbuagu OE, Moriarty JP, Huot SJ, Green ML. The Changing Face of HIV Care. Academic Medicine 2018, 93: 1673-1678. PMID: 29901657, DOI: 10.1097/acm.0000000000002317.
- Edelman EJ, Oldfield BJ, Tetrault JM. Office-Based Addiction Treatment in Primary Care Approaches That Work. Medical Clinics Of North America 2018, 102: 635-652. PMID: 29933820, DOI: 10.1016/j.mcna.2018.02.007.
- Roberts W, Shi JM, Tetrault JM, McKee SA. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users. Journal Of Addiction Medicine 2018, 12: 227-233. PMID: 29438157, PMCID: PMC5970035, DOI: 10.1097/adm.0000000000000392.
- Verplaetse TL, Weinberger AH, Ashare RL, Pittman BP, Shi JM, Tetrault JM, Lavery M, McKee SA. Pilot investigation of the effect of carvedilol on stress-precipitated smoking-lapse behavior. Journal Of Psychopharmacology 2018, 32: 1003-1009. PMID: 29692206, PMCID: PMC6258014, DOI: 10.1177/0269881118767647.
- Donroe JH, Tetrault JM. Narrowing the treatment gap in managing opioid use disorder. Canadian Medical Association Journal 2018, 190: e236-e237. PMID: 29507154, PMCID: PMC5837871, DOI: 10.1503/cmaj.180209.
- Holt SR, Donroe JH, Cavallo DA, Tetrault JM. Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. Drug And Alcohol Dependence 2018, 186: 171-174. PMID: 29579725, DOI: 10.1016/j.drugalcdep.2017.12.040.
- Deligianni M, Tetrault J. La réduction de la consommation de cannabis améliore les résultats fonctionnels au fil du temps. Revue Médicale Suisse 2018, 14: 2184. PMID: 30484980, DOI: 10.53738/revmed.2018.14.629.2184.
- Opioid Intoxication and WithdrawalTetrault JM, O’Connor PG. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Sixth Edition. Wolters Kluwer. Philadelphia, PA. 2018. Pp 741-756.
- Tetrault JM, Fiellin DA. More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic. Annals Of Internal Medicine 2017, 168: 73-74. PMID: 29159399, DOI: 10.7326/m17-2854.
- Donroe JH, Holt SR, O’Connor P, Sukumar N, Tetrault JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug And Alcohol Dependence 2017, 180: 46-51. PMID: 28866369, DOI: 10.1016/j.drugalcdep.2017.07.040.
- Tetrault JM, Petrakis IL. Partnering with Psychiatry to Close the Education Gap: An Approach to the Addiction Epidemic. Journal Of General Internal Medicine 2017, 32: 1387-1389. PMID: 28766126, PMCID: PMC5698217, DOI: 10.1007/s11606-017-4140-9.
- Holt SR, Segar N, Cavallo DA, Tetrault JM. The Addiction Recovery Clinic. Academic Medicine 2017, 92: 680-683. PMID: 28441678, DOI: 10.1097/acm.0000000000001480.
- Donroe JH, Tetrault JM. Recognizing and Caring for the Intoxicated Patient in an Outpatient Clinic. Medical Clinics Of North America 2017, 101: 573-586. PMID: 28372714, DOI: 10.1016/j.mcna.2016.12.012.
- Verplaetse TL, Weinberger AH, Oberleitner LM, Smith KM, Pittman BP, Shi JM, Tetrault JM, Lavery ME, Picciotto MR, McKee SA. Effect of doxazosin on stress reactivity and the ability to resist smoking. Journal Of Psychopharmacology 2017, 31: 830-840. PMID: 28440105, PMCID: PMC5823502, DOI: 10.1177/0269881117699603.
- Donroe JH, Tetrault JM. Substance Use, Intoxication, and Withdrawal in the Critical Care Setting. Critical Care Clinics 2017, 33: 543-558. PMID: 28601134, DOI: 10.1016/j.ccc.2017.03.003.
- Bernstein SL, Rosner J, DeWitt M, Tetrault J, Hsiao AL, Dziura J, Sussman S, O'Connor P, Toll B. Design and implementation of decision support for tobacco dependence treatment in an inpatient electronic medical record: a randomized trial. Translational Behavioral Medicine 2017, 7: 185-195. PMID: 28194729, PMCID: PMC5526813, DOI: 10.1007/s13142-017-0470-8.
- Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.
- Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O. Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs. AIDS And Behavior 2016, 21: 1025-1033. PMID: 27896552, PMCID: PMC5344709, DOI: 10.1007/s10461-016-1612-6.
- Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. Journal Of General Internal Medicine 2016, 32: 62-70. PMID: 27778215, PMCID: PMC5215171, DOI: 10.1007/s11606-016-3903-z.
- Donroe JH, Holt SR, Tetrault JM. Caring for patients with opioid use disorder in the hospitalCaring for patients with opioid use disorder in the hospital. Canadian Medical Association Journal 2016, 188: cmaj.160290. PMID: 27647616, PMCID: PMC5135493, DOI: 10.1503/cmaj.160290.
- Chambers D, Simpson L, Hill-Briggs F, Neta G, Vinson C, Chambers D, Beidas R, Marcus S, Aarons G, Hoagwood K, Schoenwald S, Evans A, Hurford M, Rubin R, Hadley T, Barg F, Walsh L, Adams D, Mandell D, Martin L, Mignogna J, Mott J, Hundt N, Kauth M, Kunik M, Naik A, Cully J, McGuire A, White D, Bartholomew T, McGrew J, Luther L, Rollins A, Salyers M, Cooper B, Funaiole A, Richards J, Lee A, Lapham G, Caldeiro R, Lozano P, Gildred T, Achtmeyer C, Ludman E, Addis M, Marx L, Bradley K, VanDeinse T, Wilson A, Stacey B, Powell B, Bunger A, Cuddeback G, Barnett M, Stadnick N, Brookman-Frazee L, Lau A, Dorsey S, Pullmann M, Mitchell S, Schwartz R, Kirk A, Dusek K, Oros M, Hosler C, Gryczynski J, Barbosa C, Dunlap L, Lounsbury D, O’Grady K, Brown B, Damschroder L, Waltz T, Powell B, Ritchie M, Waltz T, Atkins D, Imel Z, Xiao B, Can D, Georgiou P, Narayanan S, Berkel C, Gallo C, Sandler I, Brown C, Wolchik S, Mauricio A, Gallo C, Brown C, Mehrotra S, Chandurkar D, Bora S, Das A, Tripathi A, Saggurti N, Raj A, Hughes E, Jacobs B, Kirkendall E, Loeb D, Trinkley K, Yang M, Sprowell A, Nease D, Lyon A, Lewis C, Boyd M, Melvin A, Nicodimos S, Liu F, Jungbluth N, Lyon A, Lewis C, Boyd M, Melvin A, Nicodimos S, Liu F, Jungbluth N, Flynn A, Landis-Lewis Z, Sales A, Baloh J, Ward M, Zhu X, Bennett I, Unutzer J, Mao J, Proctor E, Vredevoogd M, Chan Y, Williams N, Green P, Bernstein S, Rosner J, DeWitt M, Tetrault J, Dziura J, Hsiao A, Sussman S, O’Connor P, Toll B, Jones M, Gassaway J, Tobin J, Zatzick D, Bradbury A, Patrick-Miller L, Egleston B, Olopade O, Hall M, Daly M, Fleisher L, Grana G, Ganschow P, Fetzer D, Brandt A, Farengo-Clark D, Forman A, Gaber R, Gulden C, Horte J, Long J, Chambers R, Lucas T, Madaan S, Mattie K, McKenna D, Montgomery S, Nielsen S, Powers J, Rainey K, Rybak C, Savage M, Seelaus C, Stoll J, Stopfer J, Yao S, Domchek S, Hahn E, Munoz-Plaza C, Wang J, Delgadillo J, Mittman B, Gould M, Liang S, Kegler M, Cotter M, Phillips E, Hermstad A, Morton R, Beasley D, Martinez J, Riehman K, Gustafson D, Marsch L, Mares L, Quanbeck A, McTavish F, McDowell H, Brown R, Thomas C, Glass J, Isham J, Shah D, Liebschutz J, Lasser K, Watkins K, Ober A, Hunter S, Lamp K, Ewing B, Iwelunmor J, Gyamfi J, Blackstone S, Quakyi N, Plange-Rhule J, Ogedegbe G, Kumar P, Van Devanter N, Nguyen N, Nguyen L, Nguyen T, Phuong N, Shelley D, Rudge S, Langlois E, Tricco A, Ball S, Lambert-Kerzner A, Sulc C, Simmons C, Shell-Boyd J, Oestreich T, O’Connor A, Neely E, McCreight M, Labebue A, DiFiore D, Brostow D, Ho P, Aron D, Harvey J, McHugh M, Scanlon D, Lee R, Soltero E, Parker N, McNeill L, Ledoux T, McIsaac J, MacLeod K, Ata N, Jarvis S, Kirk S, Purtle J, Dodson E, Brownson R, Mittman B, Curran G, Curran G, Pyne J, Aarons G, Ehrhart M, Torres E, Miech E, Miech E, Stevens K, I.S.R.N. Steering Council, Hamilton A, Cohen D, Padgett D, Morshed A, Patel R, Prusaczyk B, Aron D, Gupta D, Ball S, Hand R, Abram J, Wolfram T, Hastings M, Moreland-Russell S, Tabak R, Ramsey A, Baumann A, Kryzer E, Montgomery K, Lewis E, Padek M, Powell B, Brownson R, Mamaril C, Mays G, Branham K, Timsina L, Mays G, Hogg R, Fagan A, Shapiro V, Brown E, Haggerty K, Hawkins D, Oesterle S, Hawkins D, Catalano R, McKay V, Dolcini M, Hoffer L, Moin T, Li J, Duru O, Ettner S, Turk N, Chan C, Keckhafer A, Luchs R, Ho S, Mangione C, Selby P, Zawertailo L, Minian N, Balliunas D, Dragonetti R, Hussain S, Lecce J, Chinman M, Acosta J, Ebener P, Malone P, Slaughter M, Freedman D, Flocke S, Lee E, Matlack K, Trapl E, Ohri-Vachaspati P, Taggart M, Borawski E, Parrish A, Harris J, Kohn M, Hammerback K, McMillan B, Hannon P, Swindle T, Curran G, Whiteside-Mansell L, Ward W, Holt C, Santos S, Tagai E, Scheirer M, Carter R, Bowie J, Haider M, Slade J, Wang M, Masica A, Ogola G, Berryman C, Richter K, Shelton R, Jandorf L, Erwin D, Truong K, Javier J, Coffey D, Schrager S, Palinkas L, Miranda J, Johnson V, Hutcherson V, Ellis R, Kharmats A, Marshall-King S, LaPradd M, Fonseca-Becker F, Kepka D, Bodson J, Warner E, Fowler B, Shenkman E, Hogan W, Odedina F, De Leon J, Hooper M, Carrasquillo O, Reams R, Hurt M, Smith S, Szapocznik J, Nelson D, Mandal P, Teufel J. Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation. Implementation Science 2016, 11: 100. PMID: 27490260, PMCID: PMC4977475, DOI: 10.1186/s13012-016-0452-0.
- Holt S, Tetrault J. Unhealthy Alcohol Use. Clinics In Liver Disease 2016, 20: 429-444. PMID: 27373607, DOI: 10.1016/j.cld.2016.02.003.
- Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal Of Substance Use And Addiction Treatment 2016, 68: 62-67. PMID: 27431048, PMCID: PMC4976086, DOI: 10.1016/j.jsat.2016.06.002.
- Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA. Effect of Varenicline Combined with High‐Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings. Alcohol Clinical And Experimental Research 2016, 40: 1567-1576. PMID: 27246567, PMCID: PMC4930423, DOI: 10.1111/acer.13110.
- Becker WC, Tetrault JM. Medical Marijuana in Patients Prescribed Opioids A Cloud of Uncertainty. Mayo Clinic Proceedings 2016, 91: 830-832. PMID: 27234481, DOI: 10.1016/j.mayocp.2016.04.008.
- Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA. Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders. Journal Of Addiction Medicine 2016, 10: 166-173. PMID: 27159341, PMCID: PMC4880525, DOI: 10.1097/adm.0000000000000208.
- Ambulatory management of alcohol withdrawal syndromeHolt SR, Tetrault JM. Ambulatory management of alcohol withdrawal syndrome. UpToDate topic. 2016. Updated Nov 30, 2017
- Tetrault JM, Butner JL. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review. The Yale Journal Of Biology And Medicine 2015, 88: 227-33. PMID: 26339205, PMCID: PMC4553642.
- Opioid agonist treatment considerations in HIV-infected and HIV/HCV co-infected patientsInternational AIDS Society Cases on the Web Activity. October 21, 2015, Updated November 1, 2016
- Tetrault JM, McCance-Katz EF, Moody DE, Fiellin DA, Lruie BS, DInh AT, Fiellin LE. The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection. Journal Of Substance Use And Addiction Treatment 2014, 51: 70-74. PMID: 25480096, DOI: 10.1016/j.jsat.2014.10.010.
- Edelman EJ, Tetrault JM, Fiellin DA. Substance use in older HIV-infected patients. Current Opinion In HIV And AIDS 2014, 9: 317-324. PMID: 24824888, PMCID: PMC4175926, DOI: 10.1097/coh.0000000000000069.
- Galbrun G, Tetrault J. Le [i]binge drinking[/i] chez les jeunes adultes en bonne santé augmente le risque de maladies cardio-vasculaires. Revue Médicale Suisse 2014, 10: 725-725. DOI: 10.53738/revmed.2014.10.423.0725.
- Opioid Intoxication and WithdrawalTetrault JM, O'Connor. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Fifth Edition. Wolters Kluwer. Philadelphia, PA. 2014. Pp 668-685.
- Unhealthy alcohol use, including alcohol use disorderTetrault JM, O'Connor PG. Unhealthy alcohol use, including alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course assessment, and diagnosis. UpToDate Topic. December, 2014. Updated Sept 13, 2018.
- Ebert S, Tetrault J. Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers. Revue Médicale Suisse 2014, 10: 1893. PMID: 25417365, DOI: 10.53738/revmed.2014.10.445.1893.
- Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, Walley AY. 2013 Update in addiction medicine for the generalist. Addiction Science & Clinical Practice 2013, 8: 18. PMID: 24499640, PMCID: PMC3819258, DOI: 10.1186/1940-0640-8-18.
- Becker WC, Meghani S, Tetrault JM, Fiellin DA. Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S. American Journal On Addictions 2013, 23: 357-362. PMID: 24112118, DOI: 10.1111/j.1521-0391.2013.12109.x.
- Udo T, Harrison EL, Shi J, Tetrault J, McKee SA. A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration. American Journal On Addictions 2013, 22: 590-597. PMID: 24131167, PMCID: PMC3934424, DOI: 10.1111/j.1521-0391.2013.12014.x.
- Rastegar DA, Kunins HV, Tetrault JM, Walley AY, Gordon AJ, For the US Society of General Internal Medicine’s Substance Abuse Interest Group. 2012 Update in addiction medicine for the generalist. Addiction Science & Clinical Practice 2013, 8: 6. PMID: 23497615, PMCID: PMC3602093, DOI: 10.1186/1940-0640-8-6.
- Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA. Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment. Journal Of Addiction Medicine 2013, 7: 102-107. PMID: 23388678, PMCID: PMC3618545, DOI: 10.1097/adm.0b013e31827f9bdf.
- Walley AY, Tetrault JM, Friedmann PD. Integration of substance use treatment and medical care: A special issue of JSAT. Journal Of Substance Use And Addiction Treatment 2012, 43: 377-381. PMID: 23079197, DOI: 10.1016/j.jsat.2012.09.002.
- Ryan S, Martel S, Pantalon M, Martino S, Tetrault J, Thung S, Bernstein S, Auinger P, D’Onofrio G. Screening, brief intervention, and referral to treatment for alcohol and other drug use among adolescents: evaluation of a pediatric residency curriculum. Addiction Science & Clinical Practice 2012, 7: a98. PMCID: PMC3480164, DOI: 10.1186/1940-0640-7-s1-a98.
- Holt SR, Ramos J, Harma M, Cabrera F, Louis-Ashby C, Dinh A, Fiellin DA, Tetrault JM. Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical Services. The American Journal Of Drug And Alcohol Abuse 2012, 39: 121-129. PMID: 22992028, DOI: 10.3109/00952990.2012.715703.
- Tetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal Of Substance Use And Addiction Treatment 2012, 43: 433-439. PMID: 22938914, DOI: 10.1016/j.jsat.2012.07.011.
- Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous Use of Alcohol, Cigarettes, and Marijuana and Subsequent Abuse of Prescription Opioids in Young Adults. Journal Of Adolescent Health 2012, 52: 158-163. PMID: 23332479, PMCID: PMC3552239, DOI: 10.1016/j.jadohealth.2012.06.010.
- Edelman EJ, Dinh A, Radulescu R, Lurie B, D'Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE. Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot Study. The American Journal Of Drug And Alcohol Abuse 2012, 38: 539-543. PMID: 22794939, PMCID: PMC3522092, DOI: 10.3109/00952990.2012.701359.
- Ryan SA, Martel S, Pantalon M, Martino S, Tetrault J, Thung SF, Bernstein SL, Auinger P, Green ML, Fiellin DA, O'Connor P, D'Onofrio G. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency Curriculum. Substance Abuse 2012, 33: 251-260. PMID: 22738002, DOI: 10.1080/08897077.2011.640182.
- McKee SA, Weinberger AH, Shi J, Tetrault J, Coppola S. Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation. Nicotine & Tobacco Research 2012, 14: 1362-1371. PMID: 22492085, PMCID: PMC3482010, DOI: 10.1093/ntr/nts090.
- Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor P, Fiellin DA, D'Onofrio G. Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Substance Abuse 2012, 33: 168-181. PMID: 22489589, DOI: 10.1080/08897077.2011.640220.
- Holt SR, Ramos J, Harma MA, Cabrera F, Louis‐Ashby C, Dinh A, Tetrault JM, Fiellin DA. Prevalence of Unhealthy Substance Use on Teaching and Hospitalist Medical Services: Implications for Education. American Journal On Addictions 2012, 21: 111-119. PMID: 22332853, DOI: 10.1111/j.1521-0391.2011.00207.x.
- Tetrault JM, Fiellin DA. Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 2012, 72: 217-228. PMID: 22235870, PMCID: PMC3701303, DOI: 10.2165/11597520-000000000-00000.
- Tetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K, Justice AC, Fiellin DA, Team F. Hepatic Safety and Antiretroviral Effectiveness in HIV‐Infected Patients Receiving Naltrexone. Alcohol Clinical And Experimental Research 2011, 36: 318-324. PMID: 21797892, PMCID: PMC3221963, DOI: 10.1111/j.1530-0277.2011.01601.x.
- Sullivan LE, Tetrault JM, Braithwaite RS, Turner BJ, Fiellin DA. A Meta‐analysis of the Efficacy of Nonphysician Brief Interventions for Unhealthy Alcohol Use: Implications for the Patient‐Centered Medical Home. American Journal On Addictions 2011, 20: 343-356. PMID: 21679266, DOI: 10.1111/j.1521-0391.2011.00143.x.
- Tetrault JM, Fiellin DA. Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults. BMJ Mental Health 2011, 14: 30. PMID: 21266627, DOI: 10.1136/ebmh.14.1.30.
- . Medical Management in Handbook of Office Based Buprenorphine for Opioid DependenceTetrault JM, Sullivan LE, Fiellin DA, Medical Management in Handbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Medical Management in Handbook of Office Based Buprenorphine for Opioid DependenceTetrault JM, Sullivan LE, Fiellin DA. Medical Management in Handbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Medical Management in Treatment of Opioid Used DisorderHandbook of Office Based Buprenorphine for Opioid Dependence. 2011. Renner JA, Levounis P, eds. American Psychiatric Publishing. Pp 239-267.
- Tetrault JM, Fiellin DA, Niccolai LM, Sullivan LE. Substance Use in Patients with Sexually Transmitted Infections: Results from a National U.S. Survey. American Journal On Addictions 2010, 19: 504-509. PMID: 20958845, DOI: 10.1111/j.1521-0391.2010.00087.x.
- Gordon AJ, Kunins HV, Rastegar DA, Tetrault JM, Walley AY. Update in Addiction Medicine for the Generalist. Journal Of General Internal Medicine 2010, 26: 77-82. PMID: 20697971, PMCID: PMC3024103, DOI: 10.1007/s11606-010-1461-3.
- Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Opioids, Chronic Pain, and Addiction in Primary Care. Journal Of Pain 2010, 11: 1442-1450. PMID: 20627817, PMCID: PMC2955997, DOI: 10.1016/j.jpain.2010.04.002.
- Gaume J, Tetrault J. Alcool et risques cardiovasculaires chez des hommes infectés ou non par le VIH. Revue Médicale Suisse 2010, 6: 2046a-2046a. DOI: 10.53738/revmed.2010.6.268.2046a.
- Substance Use and HIVTetrault JM, Fiellin DA, Sullivan LE. Substance Use and HIV: Treatment Challenges. The AIDS Reader 2019, Vol. No. August 3, 2010
- McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E. Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers. Biological Psychiatry 2009, 66: 185-190. PMID: 19249750, PMCID: PMC2863311, DOI: 10.1016/j.biopsych.2009.01.029.
- Opioid Intoxication and WithdrawalTetrault JM, O'Connor PG. Opioid Intoxication and Withdrawal. In Principles of Addiction Medicine, Fourth Edition. Lippincott, Williams & Wilkins, Inc. Philadelphia, PA 2009, Pp 589-603.
- Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor P, Schottenfeld RS, Fiellin DA. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal Of General Internal Medicine 2008, 24: 218-225. PMID: 19089500, PMCID: PMC2628993, DOI: 10.1007/s11606-008-0881-9.
- Tetrault JM, Sauler M, Wells CK, Concato J. Reporting of Multivariable Methods in the Medical Literature. Journal Of Investigative Medicine 2008, 56: 954. PMID: 18797413, DOI: 10.2310/jim.0b013e31818914ff.
- Tetrault J, Sauler M, Wells C, Concato J. Reporting of Multivariable Methods in the Medical Literature. Journal Of Investigative Medicine 2008, 56: 954. DOI: 10.231/jim.0b013e31818914ff.
- Tetrault JM, O'Connor PG. Substance Abuse and Withdrawal in the Critical Care Setting. Critical Care Clinics 2008, 24: 767-788. PMID: 18929942, DOI: 10.1016/j.ccc.2008.05.005.
- Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug And Alcohol Dependence 2007, 94: 38-47. PMID: 18063321, DOI: 10.1016/j.drugalcdep.2007.09.018.
- Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non‐medical use of prescription opioids: results from a national US survey*. Addiction 2007, 103: 258-268. PMID: 18042194, DOI: 10.1111/j.1360-0443.2007.02056.x.
- Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review. JAMA Internal Medicine 2007, 167: 221-228. PMID: 17296876, PMCID: PMC2720277, DOI: 10.1001/archinte.167.3.221.
- What are the pulmonary effects of smoking marijuana?Tetrault JM, Crothers K. Clinical update: What are the pulmonary effects of smoking marijuana? The Journal of Respiratory Diseases. 2007, 28(6):253-254
- Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.
- Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of LiteratureKansagara DL, Tetrault J, Hamill C, Moore C, Olson B. Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature. Endocrine Practice 2006, 12: 651-655. PMID: 17229661, DOI: 10.4158/ep.12.6.651.
- Sullivan LE, Tetrault J, Bangalore D, Fiellin DA. Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence. Substance Abuse 2006, 27: 13-18. PMID: 17135176, DOI: 10.1300/j465v27n03_03.
- Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The Association Between Marijuana Smoking and Lung Cancer: A Systematic Review. JAMA Internal Medicine 2006, 166: 1359-1367. PMID: 16832000, DOI: 10.1001/archinte.166.13.1359.
Departments and Programs
Locations
1
1 of 2
- Addiction Recovery ClinicDana Clinic Building789 Howard AvenueNew Haven, CT 06519
- APT Foundation1 Long Wharf DriveNew Haven, CT 06511
1
1 of 2
- Addiction Recovery ClinicDana Clinic Building789 Howard AvenueNew Haven, CT 06519
- APT Foundation1 Long Wharf DriveNew Haven, CT 06511